Stockreport

Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05 [Seeking Alpha]

Monopar Therapeutics Inc.  (MNPR) 
PDF Monopar expects that its current funds will be sufficient to continue operations at least through December 31, 2027. More on Monopar Therapeutics Monopar Therapeutic [Read more]